TrialCNS drugs2013

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.

George T Grossberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.